1876B |
Drug Screen - Expanded, Blood |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
8031U |
Child Drug Exposure Screen, Urine |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |